3-(Aminomethyl)cyclobutanol hydrochloride, 95.0%, 1g

L-Valinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methylalanyl-N-[(1S,2S)-1-[(1R)-2-carboxy-1-methoxyethyl]-2-methylbutyl]-N-methyl-, 98%, 50mg

2,6-Di(1H-pyrazol-1-yl)isonicotinic acid, 98%, 500mg

N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90%, 100mg

anti-Keratin K7 mouse monoclonal, Ks7.18, 1 ml

2-(2,6-Dimethylcyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98+%, 250mg

Tri(cyclohexa-2,5-dien-1-yl)silane>93.0%(GC)200mg

4-Chloro-2-methylbenzofuro[3,2-d]pyrimidine, 97.0%, 100mg

6-BROMO-5-CHLORO-1-INDANONE, 95.0%, 1g

1-(3-Fluoro-4-methoxybenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

4-(2-Bromophenyl)pyridine>98.0%(GC)(T)1g

1-Bromo-4-(4-nitrophenoxy)benzene, 95.0%, 5g

2-(1-(((tert-butoxycarbonyl)amino)methyl)cyclopropyl)acetic acid, 95%, 100mg